Bessemer Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
37
| – | – | ﹤0.01% | 2625 |
|
|
2025
Q1 | $0 | Buy |
+37
| New | – | ﹤0.01% | 2697 |
|
|
2022
Q2 | – | Sell |
-81
| Closed | -$3K | – | 2025 |
|
|
2022
Q1 | $3K | Hold |
81
| – | – | ﹤0.01% | 1694 |
|
|
2021
Q4 | $3K | Hold |
81
| – | – | ﹤0.01% | 1732 |
|
|
2021
Q3 | $4K | Hold |
81
| – | – | ﹤0.01% | 1549 |
|
|
2021
Q2 | $5K | Hold |
81
| – | – | ﹤0.01% | 1432 |
|
|
2021
Q1 | $6K | Buy |
+81
| New | +$6K | ﹤0.01% | 1377 |
|
|
2019
Q1 | – | Sell |
-416
| Closed | -$40K | – | 1940 |
|
|
2018
Q4 | $40K | Buy |
416
+34
| +9% | +$3.27K | ﹤0.01% | 1371 |
|
|
2018
Q3 | $54K | Buy |
+382
| New | +$54K | ﹤0.01% | 1254 |
|
|
2017
Q4 | – | Sell |
-2,263
| Closed | -$141K | – | 1804 |
|
|
2017
Q3 | $141K | Buy |
+2,263
| New | +$141K | ﹤0.01% | 1124 |
|
|
2017
Q1 | – | Sell |
-32,764
| Closed | -$1.67M | – | 1893 |
|
|
2016
Q4 | $1.67M | Sell |
32,764
-101
| -0.3% | -$5.16K | 0.01% | 564 |
|
|
2016
Q3 | $1.51M | Buy |
32,865
+37
| +0.1% | +$1.7K | 0.01% | 518 |
|
|
2016
Q2 | $989K | Sell |
32,828
-1,021
| -3% | -$30.8K | 0.01% | 462 |
|
|
2016
Q1 | $1.09M | Buy |
33,849
+1,019
| +3% | +$32.7K | 0.01% | 453 |
|
|
2015
Q4 | $1.91M | Sell |
32,830
-1
| -0% | -$58 | 0.01% | 442 |
|
|
2015
Q3 | $1.39M | Buy |
32,831
+18,703
| +132% | +$792K | 0.01% | 493 |
|
|
2015
Q2 | $1.03M | Buy |
14,128
+14,086
| +33,538% | +$1.03M | 0.01% | 536 |
|
|
2015
Q1 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 1440 |
|